ClinicalTrials.govpublic full text
OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OC
platinum-sensitive ovarian cancer, relapsed ovarian cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 201615
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.